Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2019-03-12 2019-02-15
Drug Identification Number 02443295 02443295
Brand name NXSTAGE PUREFLOW SOLUTION RFP-209-CAN NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
Common or Proper name Hemodialysis Solution Hemodialysis Solution
Company Name NXSTAGE MEDICAL INC NXSTAGE MEDICAL INC
Ingredients SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G
Dosage form(s) SOLUTION SOLUTION
Route of administration DIALYSIS DIALYSIS
Packaging size 5 L 5 L
ATC code B05Z B05Z
ATC description HEMODIALYTICS AND HEMOFILTRATES HEMODIALYTICS AND HEMOFILTRATES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-11 2019-02-11
Estimated end date Unknown Unknown
Actual end date 2019-03-11
Shortage status Resolved Actual shortage
Company comments
Health Canada comments